Phase 1 Long COVI Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1
PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Post Acute Sequelae of COVID-19Long COVID
National Institute of Mental Health (NIMH)60 enrolled1 locationNCT06920628
Not Yet Recruiting
Phase 1
Testing the Safety and Effects of the Psychedelic Psilocin on Wellbeing and Anxiety in People with Ongoing Physical and Mental Health Conditions
Chronic Fatigue SyndromeAnorexia NervosaFibromyalgia+6 more
Tryptamine Therapeutics66 enrolled1 locationACTRN12625000949482
Not Yet Recruiting
Phase 1
low dose naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and long coronavirus disease (long COVID) symptoms
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)Long COVID
Griffith University56 enrolled1 locationACTRN12624001162505
Recruiting
Phase 1Phase 2
Effectiveness and Safety of Mesenchymal Stem Cell Therapy in Long COVID Patients
Post-Acute COVID-19 SyndromeLong COVID
Changhai Hospital76 enrolled1 locationNCT06492798
Withdrawn
Phase 1
Investigation of utility of Hyperbaric Oxygen Treatment (HBOT) for Long-COVID syndrome
Long COVID
Wesley Hyperbaric30 enrolled1 locationACTRN12622001428752